Restart Life Sciences Corp.

OTC: NMLSF · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Vancouver, BCCIK 0001689231Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 48

v0.1 · 5/100 weight · pillars only

↑ listing tenure, Piotroski F · ↓ Altman-Z, market scale

Methodology →

Revenue TTM

$98.3k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

Market cap

$1.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Restart Life Sciences Corp. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Lakewood-Amedex Biotherapeutics Inc. Common Stock——Neon Bloom, Inc.——Nu-Med Plus, Inc.23D Ovation Science Inc.23D

Key facts

CEOSteve Loutskou

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersVancouver, BC

ExchangeOTC: NMLSF

Employees—

IPO date2011-10-19

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.